-
Health Canada Issues Pregnancy Warning For Antidepressants
Newborns Whose Mothers Took SSRIs At Increased Risk Of Serious Lung Disorder On March 10, 2006 Health Canada issued a warning for women taking antidepressant drugs known as Selective Serotonin Re-uptake Inhibitors (SSRIs) —…
-
Pfizer’s Painkiller Celebrex May Increase Heart Attack Risk, Like Vioxx and Bextra
New Zealand Study Indicates This Increased Risk Is "Class Effect" of COX-2 Inhibitors Pfizer Inc.’s painkiller Celebrex doubles a patient’s risk of having a heart attack, according to a report about a New Zealand…
-
GlaxoSmithKline Will Revise “Black-box” Warning On Its Asthma Drugs Advair And Serevent
Novartis, However, Continues To Disagree With FDA About The Need To Change Label On Foradil GlaxoSmithKline has finally agreed with the FDA to revise a "black-box" warning on its asthma medications Advair and Serevent…
-
March 2006 FDA “Patient Safety News” Videos For Doctors Online
Edition Covers Tamiflu, Paxil, Avandia, Amicar and Omacor Name Confusion, and More The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care…
-
Two Studies Link Antibiotic Tequin To Side Effects That Can Be “Life Threatening”
NEJM Editorial Urges "Black-box" Warning For Tequin, And Suggests That This Antibiotic Should Be Recalled On March 1, 2006 The New England Journal of Medicine released early an article about two Canadian studies concerning…
-
FDA Reviewing Safety Of Bayer’s Heart Surgery Drug Trasylol
Studies Link Trasylol To Kidney Problems, Heart Attacks, and Strokes In mid-February 2006 the FDA issued a Public Health Advisory informing doctors and patients that the agency was evaluating the safety of Bayer AG’s…
